Retatrutide 24 mg – Triple-Agonist Research Peptide
FOR LABORATORY RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION.
Scientific Background
Retatrutide is a synthetic peptide under investigation for simultaneous
agonist activity at GLP-1,
GIP, and
glucagon receptors. Current in-vitro studies examine multi-receptor
signalling pathways and downstream metabolic-signalling events.
Specification
- Peptide Name: Retatrutide
- Content: 24 mg lyophilized powder (requires reconstitution)
- Purity: ≥ 99 % (HPLC / MS certificate available)
- Manufacturing: ISO 9001:2015 & cGMP-audited facility
- Intended Use: In-vitro laboratory research only
Storage & Handling
- Prior to reconstitution: store ≤ 8 °C in a dry environment
- After reconstitution: refrigerate 2 – 8 °C and use within 30 days
- For extended preservation: aliquot and freeze at −20 °C
- Avoid repeated freeze–thaw cycles
Compliance Notice
Supplied exclusively to qualified professionals for controlled laboratory
applications. No dosage or administration guidance is provided. Buyer assumes
responsibility for safe handling and regulatory adherence.
